|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.07(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$35.77 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
383,322 |
465,065 |
692,270 |
1,062,982 |
Total Sell Value |
$21,483,161 |
$26,035,108 |
$36,943,628 |
$50,012,228 |
Total People Sold |
4 |
7 |
9 |
11 |
Total Sell Transactions |
8 |
17 |
38 |
71 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-17 |
4 |
D |
$43.05 |
$183,178 |
D/D |
(4,255) |
97,655 |
|
- |
|
Liawatidewi Yakob |
EVP CORP ADMIN CENTER |
|
2024-03-17 |
4 |
D |
$43.05 |
$74,304 |
D/D |
(1,726) |
74,778 |
|
- |
|
Zhou Rong |
SENIOR EVP, PRODUCTION CENTER |
|
2024-03-17 |
4 |
D |
$43.05 |
$84,421 |
D/D |
(1,961) |
118,016 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-17 |
4 |
D |
$43.05 |
$303,589 |
I/I |
(7,052) |
1,229,756 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-17 |
4 |
D |
$43.05 |
$678,812 |
D/D |
(15,768) |
2,433,554 |
|
- |
|
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-16 |
4 |
D |
$43.05 |
$219,770 |
D/D |
(5,105) |
101,910 |
|
- |
|
Liawatidewi Yakob |
EVP CORP ADMIN CENTER |
|
2024-03-16 |
4 |
D |
$43.05 |
$71,937 |
D/D |
(1,671) |
76,504 |
|
- |
|
Zhou Rong |
SENIOR EVP, PRODUCTION CENTER |
|
2024-03-16 |
4 |
D |
$43.05 |
$101,383 |
D/D |
(2,355) |
119,977 |
|
- |
|
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-15 |
4 |
D |
$43.05 |
$98,369 |
D/D |
(2,285) |
107,015 |
|
- |
|
Liawatidewi Yakob |
EVP CORP ADMIN CENTER |
|
2024-03-15 |
4 |
D |
$43.05 |
$44,212 |
D/D |
(1,027) |
78,175 |
|
- |
|
Zhou Rong |
SENIOR EVP, PRODUCTION CENTER |
|
2024-03-15 |
4 |
D |
$43.05 |
$52,478 |
D/D |
(1,219) |
122,332 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
D |
$43.05 |
$8,724,427 |
I/I |
(202,658) |
1,236,808 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
OE |
$12.46 |
$3,874,188 |
I/I |
310,930 |
1,439,466 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
D |
$43.05 |
$17,595,439 |
D/D |
(408,721) |
2,449,322 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2024-03-15 |
4 |
OE |
$12.46 |
$8,996,693 |
D/D |
722,046 |
2,858,043 |
|
- |
|
Zhou Rong |
SENIOR EVP, PRODUCTION CENTER |
|
2024-03-06 |
4 |
D |
$46.31 |
$64,371 |
D/D |
(1,390) |
123,551 |
|
- |
|
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-06 |
4 |
D |
$46.31 |
$101,419 |
D/D |
(2,190) |
109,300 |
|
- |
|
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-06 |
4 |
AS |
$46.30 |
$842,883 |
D/D |
(18,136) |
111,490 |
|
-6% |
|
Peters William J |
CFO, EVP & TREASURER |
|
2024-03-06 |
4 |
OE |
$11.33 |
$99,999 |
D/D |
8,826 |
129,626 |
|
- |
|
Luo Mary Z. |
COO, Chief Scientist, Chairman |
|
2024-03-06 |
4 |
D |
$46.31 |
$138,467 |
I/I |
(2,990) |
1,128,536 |
|
- |
|
Luo Mary Z. |
COO, Chief Scientist, Chairman |
|
2024-03-06 |
4 |
D |
$46.31 |
$325,606 |
D/D |
(7,031) |
2,135,997 |
|
- |
|
Liawatidewi Yakob |
EVP CORP ADMIN CENTER |
|
2024-03-06 |
4 |
D |
$46.31 |
$56,545 |
D/D |
(1,221) |
79,202 |
|
- |
|
Zasloff Michael A |
|
|
2024-03-05 |
4 |
S |
$47.06 |
$589,724 |
D/D |
(12,500) |
21,326 |
|
8% |
|
Zhou Rong |
SENIOR EVP, PRODUCTION CENTER |
|
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,521 |
124,941 |
|
- |
|
Luo Mary Z. |
COO, Chief Scientist, Chairman |
|
2024-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
27,110 |
1,131,526 |
|
- |
|
953 Records found
|
|
Page 1 of 39 |
|
|